These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17505527)

  • 1. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
    Girelli D; Martinelli N; Trabetti E; Olivieri O; Cavallari U; Malerba G; Busti F; Friso S; Pizzolo F; Pignatti PF; Corrocher R
    Eur J Hum Genet; 2007 Sep; 15(9):959-66. PubMed ID: 17505527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
    Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
    Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
    J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
    Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
    Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
    Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
    Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis.
    Zintzaras E; Rodopoulou P; Sakellaridis N
    Am J Epidemiol; 2009 Mar; 169(5):523-32. PubMed ID: 19126581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
    Zee RY; Cheng S; Hegener HH; Erlich HA; Ridker PM
    Stroke; 2006 Aug; 37(8):2007-11. PubMed ID: 16778124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.
    Kostulas K; Gretarsdottir S; Kostulas V; Manolescu A; Helgadottir A; Thorleifsson G; Gudmundsson LJ; Thorsteinsdottir U; Gulcher JR; Stefansson K; Hillert J
    J Neurol Sci; 2007 Dec; 263(1-2):113-7. PubMed ID: 17655870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
    Linsel-Nitschke P; Götz A; Medack A; König IR; Bruse P; Lieb W; Mayer B; Stark K; Hengstenberg C; Fischer M; Baessler A; Ziegler A; Schunkert H; Erdmann J
    Clin Sci (Lond); 2008 Nov; 115(10):309-15. PubMed ID: 18318662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
    Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
    Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.
    Wiedmann S; Neureuther K; Stark K; Reinhard W; Kallmünzer B; Baessler A; Fischer M; Linsel-Nitschke P; Erdmann J; Schunkert H; Hengstenberg C
    Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of ALOX5AP haplotypes with susceptibility to coronary artery disease in a Chinese Han population.
    Li Y; Li Z; Zhang X; Yan C; Kang J; Liang Z; Liu S; Feng X; Han Y
    Eur J Intern Med; 2012 Jul; 23(5):e119-23. PubMed ID: 22726381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
    Cavallari U; Trabetti E; Malerba G; Biscuola M; Girelli D; Olivieri O; Martinelli N; Angiolillo DJ; Corrocher R; Pignatti PF
    BMC Med Genet; 2007 Sep; 8():59. PubMed ID: 17803810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
    Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
    J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
    Helgadottir A; Manolescu A; Thorleifsson G; Gretarsdottir S; Jonsdottir H; Thorsteinsdottir U; Samani NJ; Gudmundsson G; Grant SF; Thorgeirsson G; Sveinbjornsdottir S; Valdimarsson EM; Matthiasson SE; Johannsson H; Gudmundsdottir O; Gurney ME; Sainz J; Thorhallsdottir M; Andresdottir M; Frigge ML; Topol EJ; Kong A; Gudnason V; Hakonarson H; Gulcher JR; Stefansson K
    Nat Genet; 2004 Mar; 36(3):233-9. PubMed ID: 14770184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction.
    Maznyczka A; Mangino M; Whittaker A; Braund P; Palmer T; Tobin M; Goodall AH; Bradding P; Samani NJ
    Clin Sci (Lond); 2007 Jun; 112(7):411-6. PubMed ID: 17176247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.